BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16861219)

  • 1. HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes.
    Zhou H; Gurley EC; Jarujaron S; Ding H; Fang Y; Xu Z; Pandak WM; Hylemon PB
    Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1071-80. PubMed ID: 16861219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indinavir alters sterol and fatty acid homeostatic mechanisms in primary rat hepatocytes by increasing levels of activated sterol regulatory element-binding proteins and decreasing cholesterol 7alpha-hydroxylase mRNA levels.
    Williams K; Rao YP; Natarajan R; Pandak WM; Hylemon PB
    Biochem Pharmacol; 2004 Jan; 67(2):255-67. PubMed ID: 14698038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia.
    Lum PY; He YD; Slatter JG; Waring JF; Zelinsky N; Cavet G; Dai X; Fong O; Gum R; Jin L; Adamson GE; Roberts CJ; Olsen DB; Hazuda DJ; Ulrich RG
    Genomics; 2007 Oct; 90(4):464-73. PubMed ID: 17719200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of HIV protease inhibitor-induced dysregulation of hepatic lipid metabolism by raltegravir via endoplasmic reticulum stress signaling pathways.
    Cao R; Hu Y; Wang Y; Gurley EC; Studer EJ; Wang X; Hylemon PB; Pandak WM; Sanyal AJ; Zhang L; Zhou H
    J Pharmacol Exp Ther; 2010 Aug; 334(2):530-9. PubMed ID: 20472667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism.
    Kim RJ; Wilson CG; Wabitsch M; Lazar MA; Steppan CM
    Obesity (Silver Spring); 2006 Jun; 14(6):994-1002. PubMed ID: 16861604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal.
    Yan Q; Hruz PW
    J Acquir Immune Defic Syndr; 2005 Dec; 40(4):398-403. PubMed ID: 16280693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers.
    Tomaka F; Lefebvre E; Sekar V; Van Baelen B; Vangeneugden T; Vandevoorde A; Diego Miralles G
    HIV Med; 2009 May; 10(5):318-27. PubMed ID: 19210693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.
    Swindells S; DiRienzo AG; Wilkin T; Fletcher CV; Margolis DM; Thal GD; Godfrey C; Bastow B; Ray MG; Wang H; Coombs RW; McKinnon J; Mellors JW;
    JAMA; 2006 Aug; 296(7):806-14. PubMed ID: 16905786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of rats.
    Yang Y; Dahly-Vernon AJ; Blomme EA; Lai-Zhang J; Kempf DJ; Marsh KC; Harrington YA; Nye SH; Evans DL; Roman RJ; Jacob HJ; Waring JF
    Vet J; 2010 Jul; 185(1):75-82. PubMed ID: 20547082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease.
    Zhou H; Pandak WM; Lyall V; Natarajan R; Hylemon PB
    Mol Pharmacol; 2005 Sep; 68(3):690-700. PubMed ID: 15976036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice.
    Chung MJ; Sung NJ; Park CS; Kweon DK; Mantovani A; Moon TW; Lee SJ; Park KH
    Eur J Pharmacol; 2008 Jan; 578(2-3):159-70. PubMed ID: 17976573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV protease inhibitors increase TNF-alpha and IL-6 expression in macrophages: involvement of the RNA-binding protein HuR.
    Zhou H; Jarujaron S; Gurley EC; Chen L; Ding H; Studer E; Pandak WM; Hu W; Zou T; Wang JY; Hylemon PB
    Atherosclerosis; 2007 Nov; 195(1):e134-43. PubMed ID: 17531241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytes.
    Zha BS; Wan X; Zhang X; Zha W; Zhou J; Wabitsch M; Wang G; Lyall V; Hylemon PB; Zhou H
    PLoS One; 2013; 8(3):e59514. PubMed ID: 23533630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus protease inhibitors modulate Ca2+ homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes.
    Kao E; Shinohara M; Feng M; Lau MY; Ji C
    Hepatology; 2012 Aug; 56(2):594-604. PubMed ID: 22407670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjects.
    McRae M; Clay PG; Anderson PL; Glaros AG
    Pharmacotherapy; 2009 Aug; 29(8):937-42. PubMed ID: 19637947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors.
    Woo CW; Siow YL; Pierce GN; Choy PC; Minuk GY; Mymin D; O K
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1002-10. PubMed ID: 15644462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors.
    Ye ZW; Augustijns P; Annaert P
    Drug Metab Dispos; 2008 Jul; 36(7):1315-21. PubMed ID: 18420783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV protease inhibitors induce metabolic dysfunction in part via increased JNK1/2 pro-inflammatory signaling in L6 cells.
    Bogachus LD; Turcotte LP
    Antiviral Res; 2011 Dec; 92(3):415-23. PubMed ID: 21968131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir.
    Busti AJ; Bedimo R; Margolis DM; Hardin DS
    J Investig Med; 2008 Feb; 56(2):539-44. PubMed ID: 18317438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
    Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
    Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.